Johnson & Johnson (JNJ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · United States · ISIN US4781601046
Johnson & Johnson financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 94.19 bn USD |
| Gross profit | 63.94 bn USD |
| EBIT | 32.50 bn USD |
| Net income | 26.80 bn USD |
| Diluted EPS – continuing operations | 11.03 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
More stocks
- Walmart (WMT)
- JPMorgan Chase (JPM)
- Bryn Inc. (BRRN)
- Visa Inc. (V)
- ExxonMobil (XOM)
- ASML Holding NV (ASML.AS)
- Mastercard (MA)
- BeOne Medicines Ltd. (ONC)
- Palantir Technologies (PLTR)
- AbbVie (ABBV)
- Intel (INTC)
- Tencent Holdings Ltd (700.HK)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.